PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
28109921-1	2017	OBJECTIVES: The aims of this study were to describe the authors" initial experience with combined coronary artery positron emission tomographic (PET) and magnetic resonance (MR) imaging using 18F-fluorodeoxyglucose (18F-FDG) and 18F-sodium fluoride (18F-NaF) radiotracers, describe common problems and their solutions, and demonstrate the feasibility of coronary PET/MR imaging in appropriate patients.	Fluorodeoxyglucose F18	192-214	C-X-C motif chemokine ligand 8	Homo sapiens	254-257	
30006643-10	2018	Body mass index positively correlated with 18F-FDG uptake in the soft tissue (r=0.53, P<0.0001), osseous compartment (r=0.58, P<0.0001) and 18F-NaF uptake in the joint (r=0.37, P=0.0001).	Fluorodeoxyglucose F18	43-50	C-X-C motif chemokine ligand 8	Homo sapiens	150-153	
26140472-7	2016	The SUVmax of (18)F-FDG correlated with that of (18)F-NaF in individual joints (r = 0.65), though detail distribution was different between two tracers.	Fluorodeoxyglucose F18	20-23	C-X-C motif chemokine ligand 8	Homo sapiens	54-57	
26147617-10	2016	The 18F-NaF/18F-FDG showed that, overall, 18F-NaF uptake is higher than 18F-FDG.	Fluorodeoxyglucose F18	12-19	C-X-C motif chemokine ligand 8	Homo sapiens	46-49	
26147617-10	2016	The 18F-NaF/18F-FDG showed that, overall, 18F-NaF uptake is higher than 18F-FDG.	Fluorodeoxyglucose F18	72-79	C-X-C motif chemokine ligand 8	Homo sapiens	8-11	
25097896-1	2014	Our aim was to establish an easy and convenient procedure for the preparation of fluorine-18-sodium fluoride ((18)F-NaF) for bone positron emission tomography (PET) during routine (18)F-FDG production using the Explora FDG4 radiochemistry module (EFRM) by single run of Cyclotron with negligible radiation exposure.	Fluorodeoxyglucose F18	186-189	C-X-C motif chemokine ligand 8	Homo sapiens	116-119	
24145180-0	2013	Level of TNF-related apoptosis-inducing-ligand and CXCL8 correlated with 2-[18F]Fluoro-2-deoxy-D-glucose uptake in anti-VEGF treated colon cancers.	Fluorodeoxyglucose F18	73-104	C-X-C motif chemokine ligand 8	Homo sapiens	51-56	
20663736-4	2010	With the advent of hybrid positron emission tomography (PET)/CT scanners there has been an increasing interest in using various PET tracers to evaluate skeletal disease including [(18)F]fluoride (NaF) as a bone-specific tracer and [(18)F]fluorodeoxyglucose and [(18)F]choline as tumour-specific tracers.	Fluorodeoxyglucose F18	238-256	C-X-C motif chemokine ligand 8	Homo sapiens	196-199	
21826964-5	2011	However, BS and 18F-NaF PET/CT are more sensitive for sclerotic lesions, as a decreased 18F-FDG uptake in this subtype of lesion has been reported.	Fluorodeoxyglucose F18	88-95	C-X-C motif chemokine ligand 8	Homo sapiens	20-23	
31667675-2	2020	We sought to address this limitation by utilizing the distinctively high bone uptake rate constant Ki expected from 18F-Sodium Fluoride (18F-NaF) to segment bones from PET data and support 5-class hybrid PET/MR-driven AC for 18F-NaF and 18F-Fluorodeoxyglucose (18F-FDG) PET/MR cardiovascular imaging.	Fluorodeoxyglucose F18	237-259	C-X-C motif chemokine ligand 8	Homo sapiens	141-144	
31667675-2	2020	We sought to address this limitation by utilizing the distinctively high bone uptake rate constant Ki expected from 18F-Sodium Fluoride (18F-NaF) to segment bones from PET data and support 5-class hybrid PET/MR-driven AC for 18F-NaF and 18F-Fluorodeoxyglucose (18F-FDG) PET/MR cardiovascular imaging.	Fluorodeoxyglucose F18	261-268	C-X-C motif chemokine ligand 8	Homo sapiens	141-144	
31667675-9	2020	In the R4:1 human cohort, the mean 18F-FDG:18F-NaF TBR increased by 12.2% at carotid bifurcations wall and 19.9% at vertebral bones.	Fluorodeoxyglucose F18	35-42	C-X-C motif chemokine ligand 8	Homo sapiens	47-50	
32821713-6	2019	FDG uptake at symptomatic carotid arteries was significantly more increased than that at asymptomatic arteries (TBR: 1.17+-0.23 vs. 1.01+-0.15, Mann-Whitney U-test, p=0.02), but NaF uptake was not different (TBR: 1.38+-0.49 vs. 1.51+-0.40, p=0.40).	Fluorodeoxyglucose F18	0-3	C-X-C motif chemokine ligand 8	Homo sapiens	178-181